Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/10/1989 | CA1262239A1 Propagation process |
10/10/1989 | CA1262238A1 Human monoclonal antibodies against bacterial toxins |
10/05/1989 | WO1989009404A2 Macromolecular conjugate |
10/05/1989 | WO1989009403A1 Diagnostic methods and systems for quantifying apo ai |
10/05/1989 | WO1989009393A1 Luminescent chimeric proteins |
10/05/1989 | WO1989009286A1 PROTAMINE-REACTIVE IgM ANTIBODIES |
10/05/1989 | WO1989009284A1 Catalytic hybridization systems for the detection of nucleic acid sequences based on their activity as cofactors in catalytic reactions in which a complementary labeled nucleic acid probe is cleaved |
10/05/1989 | WO1989009282A1 Method of sequencing dna |
10/05/1989 | WO1989009278A1 Method of degrading keratinaceous material and bacteria useful therefor |
10/05/1989 | WO1989009277A1 Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression |
10/05/1989 | WO1989009272A1 A transgenic mouse for measurement and characterization of mutation induction in vivo |
10/05/1989 | WO1989009271A1 Recombinant retroviruses |
10/05/1989 | WO1989009269A1 The gene encoding phosphoribosylaminoimidazolecarboxylase of schwanniomyces occidentalis |
10/05/1989 | WO1989009268A1 Production of insulin-like growth factor binding protein |
10/05/1989 | WO1989009267A2 Dna promoter fragments from wheat |
10/05/1989 | WO1989009266A1 Novel human tissue plasminogen activator variants and processes |
10/05/1989 | WO1989009265A1 Apparatus and method for automated purification of extra-chromosomal dna from a cell suspension in a container |
10/05/1989 | WO1989009264A1 DNA SEQUENCES CONTAINING THE FUNCTIONAL PART OF THE LOCUS sacU AND OF THE LOCUS sacUh OF B. SUBTILIS, VECTORS CONTAINING SAID SEQUENCES AND THEIR USE IN PROTEIN PRODUCING PROCESSES |
10/05/1989 | WO1989009263A1 Molecular cloning and expression of genes encoding lipolytic enzymes |
10/05/1989 | WO1989009262A2 Transgenic plant with modified physiology, morphology and modified hormone metabolism, tissue cultures of this plant and process for its preparation |
10/05/1989 | WO1989009261A1 Diagnosis of mycobacterium bovis infection |
10/05/1989 | WO1989009260A1 Ryegrass pollen allergen |
10/05/1989 | WO1989009256A1 Regulation of gene expression |
10/05/1989 | WO1989009234A1 Therapeutic murine monoclonal antibody |
10/05/1989 | WO1989009232A1 Neuropeptide antagonists |
10/05/1989 | WO1989009228A1 Peptides |
10/05/1989 | WO1989009227A2 Pf10 to pf19 peptides of an hiv retrovirus, process for synthetizing said peptides and their use, in particular for diagnosis |
10/05/1989 | WO1989009223A1 Dna binding proteins including androgen receptor |
10/05/1989 | WO1989009222A1 Cloned human topoisomerase i |
10/05/1989 | WO1989009220A1 THE HUMAN C3b/C4b RECEPTOR (CR1) |
10/05/1989 | WO1989009219A1 Artificial chromosome vector |
10/05/1989 | WO1989009063A1 Novel non-reverting shigella live vaccines |
10/05/1989 | DE3908131A1 Dna mit genetischer information von lipase Dna with genetic information of lipase |
10/05/1989 | DE3810474A1 Expression vectors |
10/04/1989 | EP0335854A2 Regulated gene expression in gram-negative microorganisms |
10/04/1989 | EP0335654A2 Odorant-binding protein from rat |
10/04/1989 | EP0335573A2 Method for producing 2'''-0-demethyltylosin |
10/04/1989 | EP0335567A2 Controlled release of periplasmic proteins into the medium |
10/04/1989 | EP0335476A2 Recombinant methods for the production of ricin a, ricin b, ricin or diphtheria toxin (dt)a or ab' fragment, suitable hosts and vectors therefor, and conjugates comprising ricin toxin a chain or diphtheria toxin |
10/04/1989 | EP0335451A2 Genetically engineered plant cells and plants, as well as recombinant DNA suitable therefor |
10/04/1989 | EP0335400A2 Processes for production of human epidermal growth factor by genetic engineering |
10/04/1989 | EP0335243A2 Mutant human angiogenin (angiogenesis factor with superior angiogenin activity) genes therefor and methods of expression |
10/04/1989 | EP0335134A2 Mouse monoclonal antibody to human immunodeficiency virus gp41 protein |
10/04/1989 | EP0334970A2 Genetic system for micromonospora |
10/04/1989 | EP0334904A1 Process for inactivating recombinant dna |
10/04/1989 | EP0334841A1 Micro-organisms and plasmids for producing 2,4-dichlorophenoxy acetic acid (2,4-d)-monooxygenase and process for producing these plasmids and strains. |
10/04/1989 | CN1036038A Chimeric gene for herbicidal resistance |
10/04/1989 | CN1036037A Method of producing rice cybrid cells |
10/04/1989 | CN1035953A Binding-inducing composition |
10/03/1989 | US4871835 Analogs of hGH having antagonistic activity, and uses thereof |
10/03/1989 | US4871834 Anticarcinogenic agents, genetic engineering |
10/03/1989 | US4871670 Dna transfer vector |
10/03/1989 | US4871663 Exporession vector for human TnF |
09/27/1989 | EP0334539A2 Genetic manipulation |
09/27/1989 | EP0334530A1 A recombinant marek's disease virus and a vaccine |
09/27/1989 | EP0334391A1 Process for preparing L-isoleucine |
09/27/1989 | EP0334383A2 Transgenic plant with modified physiology, morphology and modified hormone metabolism, tissue cultures of this plant and process for its preparation |
09/27/1989 | EP0334301A1 Recombinant retroviruses |
09/27/1989 | EP0334283A2 Process for the selection of large DNA segments |
09/27/1989 | EP0334282A2 Use of pSG5 as a temperature-sensitive plasmid |
09/27/1989 | EP0334165A2 Monoclonal antibodies |
09/27/1989 | EP0334004A1 Isolation, purification, characterization, cloning and sequencing of N-alpha-acetyltransferase |
09/27/1989 | EP0333832A1 Artificial dna base pair analogues |
09/27/1989 | EP0333813A1 Method for fixing and separating molecules comprising at least one natural or synthetic dna fragment |
09/27/1989 | EP0333799A1 Modifying living cells |
09/27/1989 | CN1035845A Cloning and expression of transforming growth factor beta 2 |
09/26/1989 | US4870163 Purification by multistage adsorption |
09/26/1989 | US4870159 Leucine-specific regulatory locus |
09/26/1989 | US4870023 Recombinant baculovirus occlusion bodies in vaccines and biological insecticides |
09/26/1989 | US4870021 Pure culture of antibiotic A42125-producing strains of Nocardia aerocolonigenes |
09/26/1989 | US4870017 Bacterial methionine N-terminal peptidase |
09/26/1989 | US4870015 Dna sequences, genetic engineering |
09/26/1989 | US4870014 Cloning of thermolabile glucoamylase gene into saccharomyces cerevisiae |
09/26/1989 | US4870013 SV40 early and RSV promoters useful in saccharomyces expression |
09/26/1989 | US4870012 Bacterial method and compositions for linalool degradation |
09/26/1989 | US4870009 Hormones |
09/26/1989 | US4870008 Secretory expression in eukaryotes |
09/26/1989 | EP0329693A4 Human pancreatic secretory trypsin inhibitors produced by recombinant dna methods and processes for the production of same. |
09/26/1989 | EP0216864A4 Detection of activated platelets with antibodies to cell surface antigens. |
09/26/1989 | CA1261751A1 Fused liposome and acid induced method for liposome fusion |
09/26/1989 | CA1261287A1 Method for transforming a cephalosporium cell |
09/26/1989 | CA1261286A2 Antigens and monoclonal antibodies reactive against merozoites of eimeria spp |
09/26/1989 | CA1261285A2 Antigens and monoclonal antibodies reactive against sporozoites of eimeria spp |
09/26/1989 | CA1260858A1 Expression using fused genes providing for protein product |
09/26/1989 | CA1260372A1 Hybridization method for the detection of genetic materials |
09/26/1989 | CA1259934A1 Non-reverting salmonella live vaccines |
09/26/1989 | CA1259921A1 Non-a non-b hepatitis antigens |
09/26/1989 | CA1259920A1 Immunotoxin and method of making |
09/21/1989 | WO1989008845A1 Antibodies, process for producing them, oligosaccharide haptens and clones for the production of the antibodies, and use of the antibodies for diagnosis and therapy of tumours |
09/21/1989 | WO1989008842A1 Placental isoferritins for the prognosis and diagnosis of immunosuppression |
09/21/1989 | WO1989008716A1 Novel recombinant vaccinia virus expression vectors and method of selecting same |
09/21/1989 | WO1989008712A1 Oxygen regulatable gene expression |
09/21/1989 | WO1989008711A1 Monoclonal antibodies and vaccine development directed to human cancer-associated antigens by immunization with animal and human mucin and with synthetic carbohydrate-carrier conjugates |
09/21/1989 | WO1989008708A1 Ribosome binding site |
09/21/1989 | WO1989008707A1 Novel modified nad-dependent dehydrogenases and process for their production |
09/21/1989 | WO1989008706A1 Isoforms of trophoblastine, new interferons composed of said isoforms, their manner of production and applications |
09/21/1989 | WO1989008700A1 Diagnostic genes for toxoplasmosis |
09/21/1989 | WO1989008667A1 Recombinant igf binding protein (ibp-1) |
09/21/1989 | WO1989008666A1 Heparin-binding proteins, dna cuding for them, processes for producing them as well as therapeutic preparations containing them |
09/21/1989 | WO1989008665A1 NOVEL NEUTROPHIL CHEMOTACTIC FACTOR, CLONED cDNA AND MONOCLONAL ANTIBODIES THERETO |